Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis

Pediatr Blood Cancer. 2007 Oct 15;49(5):758-60. doi: 10.1002/pbc.20647.

Abstract

Due to high rates of recurrence, the prognosis of childhood ependymoma remains guarded. Anecdotal evidence suggests that tamoxifen may have a role in the treatment of these tumors. We present a case of a child with recurrent ependymoma treated with tamoxifen who showed tumor regression on two separate occasions. However, treatment with tamoxifen resulted in the development of large ovarian cysts associated with supraphysiological plasma concentrations of estradiol.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Ependymoma / complications*
  • Ependymoma / drug therapy*
  • Estradiol / blood
  • Female
  • Humans
  • Ovarian Cysts / chemically induced*
  • Puberty
  • Recurrence
  • Tamoxifen / pharmacology*
  • Tamoxifen / therapeutic use
  • Tumor Burden / drug effects

Substances

  • Tamoxifen
  • Estradiol